Oriental Research AlliaNce of Acute Ischemic Stroke Given Endovascular Treatment

Recruiting now

Conditions studied: Ischemic Stroke

In brief

To determine the safety and efficacy of in situ ischemic postconditioning immediately after successful reperfusion in AIS patients underwnet EVT.

Key facts

Study ID

NCT05024292

Run by

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

People needed

160

Starts

2022-01-01

Expected to finish

2027-04-01

Last updated by the study team

2023-07-12

Who can join

Age: 18 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (age ≥ 18 to 95 years) patients with an occlusion of the internal carotid artery or M1 or M2 segment of the middle cerebral artery,;
• Patients with a score of at least 6 on the National Institutes of Health Stroke Scale (NIHSS) at admission and a score of 0 or 1 on the modified Rankin scale before the onset of stroke;
• Patients with a score of at least 6 on the Alberta Stroke Program Early CT score (ASPECTS) value;
• Baseline multimodal-CT imaging, including NCCT, CTA and CTP, performed at the trial-site hospital
• The modified thrombolysis in cerebral infarction (mTICI) scale 2b to 3 achieved in the infarct-related artery after the last thrombectomy attempt

You may not qualify if…

• Stoke of large artery atherosclerotic origin or other determined factors (such as dissection) or tandem occlusion;
• Patients underwent rescue angioplasty or stenting after thrombectomy

Where it is running

• Zhangzhou Municipal Hospital of Fujian Province — Zhangzhou, Fujian, China (enrolling)
• Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine — Shanghai, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.